Abiopharma

🔍 Valantine Hannah (Executive)

Company: CareDx, Inc. (CDNA)

Report Date: 2026-06-12

Detailed Transactions and Holdings:

• Acquired 9,795 shares of Common Stock (Direct)
  Date: 2026-06-12 | Code: A | equity_swap_involved: 0 | shares_owned_after: 48,789.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 12,103 shares of Common Stock at $23.1123 per share (Direct)
  Date: 2026-06-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 36,686.00 | transaction_form_type: 4 | Footnotes: F2, F3

Footnotes:

• F1: The reported securities are represented by restricted stock units ("RSUs"), of which the RSUs vests 100% on the earlier of the one year anniversary of grant or the day immediately before the first Annual Meeting that occurs after the grant date., subject to the Reporting Person's continuous service on each applicable vesting date.
• F2: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2025.
• F3: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.30 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.